CompanyProfileNomu
Actions
AME Company for Medical Supplies
- Nomu - Parallel Market
- Health Care Equipment & Svc
Stats Overview
-
Prev. Close 126.50
-
Open 127.20
-
High 140.00
-
Low 123.10
-
No. Of Trades 189
-
Avg. Trade size* 266
-
Volume Traded 50,202
-
Value Traded (^) 6,684,209.30
Performance
- *Average Trade Size = Cumulative / # of Trades
- **52 Week Price Change = (Current Price - Price year ago) / Price year ago x 100
- Historical prices & volume traded data are adjusted to account for all corporate actions.
- MO: Market Order
Trade Updates
Trade Updates
Best Bid
Best Offer
52 WEEK
PERFORMANCE
Compare Selected
Select A Maximum Of 5 Companies
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions
AnnouncmentandCorporateAction
Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Announcements
Corporate Actions
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Dividends
| Announced Date | Eligibility Date | Distribution Date | Distribution Way | Dividend Amount |
|---|---|---|---|---|
| 24/03/2025 | 25/05/2025 | 11/06/2025 | Account Transfer | ^2.00 |
| 25/03/2024 | 23/06/2024 | 03/07/2024 | Account Transfer | ^2.00 |
| 22/03/2023 | 18/06/2023 | 06/07/2023 | Account Transfer | ^2.00 |
| 17/04/2022 | 15/06/2022 | 27/06/2022 | Account Transfer | ^1.75 |
CompanyProfileNomuv2Financials
Actions
- Announcements & Corporate Actions
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Financials
- FINANCIAL INFORMATION
- FINANCIAL STATEMENTS AND REPORTS
- Annually
- Semi-Annual
| Balance Sheet | ||||
|---|---|---|---|---|
| Total Assets | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) | - | - | - | - |
| Total Liabilities and Shareholders Equity | - | - | - | - |
| Statement of Income | ||||
| Total Revenue (Sales/Operating) | - | - | - | - |
| Net Profit (Loss) before Zakat and Tax | - | - | - | - |
| Zakat and Income Tax | - | - | - | - |
| Net Profit (Loss) after Zakat and Tax | - | - | - | - |
| Total Comprehensive Income | - | - | - | - |
| Profit (Loss) per Share | - | - | - | - |
| Cash Flows | ||||
| Net Cash From Operating Activities | - | - | - | - |
| Net Cash From Investing Activities | - | - | - | - |
| Net Cash From Financing Activities | - | - | - | - |
| Cash and Cash Equivalents, Beginning of the Period | - | - | - | - |
| Cash and Cash Equivalents, End of the Period | - | - | - | - |
| All Figures in | ||||
| All Currency In | ||||
| Last Update Date |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
| Balance Sheet | 2023-06-30 | |||
|---|---|---|---|---|
| Total Assets |
174,960
|
- | - | - |
| Total Liabilities |
59,404
|
- | - | - |
| Total Shareholders Equity (After Deducting the Minority Equity) |
115,556
|
- | - | - |
| Total Liabilities and Shareholders Equity |
174,960
|
- | - | - |
| Statement of Income | 2023-06-30 | |||
| Total Revenue (Sales/Operating) |
120,337
|
- | - | - |
| Net Profit (Loss) before Zakat and Tax |
24,356
|
- | - | - |
| Zakat and Income Tax |
2,159
|
- | - | - |
| Net Profit (Loss) after Zakat and Tax |
22,197
|
- | - | - |
| Total Comprehensive Income |
22,197
|
- | - | - |
| Profit (Loss) per Share |
3.17
|
- | - | - |
| Cash Flows | 2023-06-30 | |||
| Net Cash From Operating Activities |
19,266
|
- | - | - |
| Net Cash From Investing Activities |
-1,544
|
- | - | - |
| Net Cash From Financing Activities |
-14,624
|
- | - | - |
| Cash and Cash Equivalents, Beginning of the Period |
23,231
|
- | - | - |
| Cash and Cash Equivalents, End of the Period |
26,419
|
- | - | - |
| All Figures in | Thousands | |||
| All Currency In | ^ | |||
| Last Update Date | 2023-10-05 |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
- Announcements & Corporate Actions
- Dividends
- Financials
- Shareholding
- Peer Comparison
- Company Profile
Company Profile
Company overview
The company distributes and markets medical products, preparations, supplies, equipment and devices primarily used in the field of cosmetics and plastic surgery in the Kingdom of Saudi Arabia.
Company History
AME Company was established in 2009 in Jeddah, Saudi Arabia, as a specialized supplier in the aesthetic medicine sector. AME Company'' mission is to provide the highest quality products and services, while maintaining continuous innovation. This commitment meets the aspirations and needs of the aesthetic medicine market in the Kingdom, and contributes to serving both patients and healthcare providers with efficiency and professionalism.
Company Bylaws
Equity Profile
- Authorized Capital (^) 70,000,000
- Issued Shares 7,000,000
- Paid Up Capital (^) 70,000,000
- Par Value/Share 10
- Paid Up Value/Share 10
Last Update :2022-01-18
Investment limits
There are no restrictions on the company's shares, as stated in both the rules regulating the investment of qualified foreign financial institutions in listed securities and the instructions regulating the ownership of strategic shares by foreign strategic investors in listed companies, in accordance with the company's articles of association and the instructions issued by the supervisory and regulatory authorities to which the company is subject.
- Company Details
- BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
Investor Relations
Contact Name:
Investor Relations
Company Address:
2139 H43V+R8 Ar Rawdah, Jeddah 23431
Contact Details:
Telephone: 0122750203
Fax: -
Email: investor.relations@ame.med.sa
Company Website:
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
- ${title}${badge}